Relapsed/Refractory Primary Central Nervous System Lymphoma
1 competing product in clinical development for Relapsed/Refractory Primary Central Nervous System Lymphoma.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tirabrutinib + Rituximab + Temozolomide | Ono Pharmaceutical | Phase 3 | Recruiting | 47 |